Answer
Viral load should be monitored closely during pregnancy with Emtricitabine/Rilpivirine/Tenofovir Disoproxil Gilead because rilpivirine exposure is reduced, and similarly low exposure in Phase III studies was associated with increased risk of virological failure.
Sources for this answer
- Emtricitabine/Rilpivirine/Tenofovir Disoproxil Gilead 200 mg/25 mg/245 mg film coated tabletsGilead Sciences Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 33Document updated
Sources checked